1 / 3
google
Article details
- Package size
- 90
- Selling units
- 90
- Measure
- Kapsel(n)
- Galenic form
- Kapseln
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
acipimoxum
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
amylum pregelificatum
|
- | Substance | HNIDK |
|
silica colloidalis
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | HNIDK |
|
natrium
|
0.05 MG | Substance | HBESI |
|
gelatina
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 47644
- Drug name
- Olbetam, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- C10AD06
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- B
- First authorization
- 20/06/1986
- Authorization expiration date
- 30/09/2025
- IT Number
- 07.12.0.
- Domain
- Human medicine
Package details
- Description (FR)
- OLBETAM caps 250 mg 90 pce
- Description (DE)
- OLBETAM Kaps 250 mg 90 Stk
- Market launch
- 20/06/1986
- Market withdrawal
- 30/09/2025
- Narcotic (BTM)
- No
Other package sizes (1)
OLBETAM 250 caps 250 mg 30 pce
None None
GTIN: 7680476440116